Global Equity Volatility: ChiNext 50 Index Declines 2% Last Week

Deep News03-10

Last week, influenced by geopolitical conflicts, the A-share market generally trended downward. The CSI 300 Index fell by 1.07%, the CSI 500 Index dropped by 3.44%, the CSI 1000 Index declined by 3.64%, the ChiNext 50 Index decreased by 2.00%, and the STAR 50 Index saw a 4.95% drop. In terms of trading activity, the average daily turnover in the A-share market was approximately 2.6 trillion yuan, indicating strong investor enthusiasm. Market focus was concentrated on sectors such as power grid equipment, CPO, quantum technology, new energy, and oil and petrochemicals, with these sectors exhibiting rapid rotation characteristics. It is advisable to monitor the high-end manufacturing sector, which benefits from the global manufacturing recovery, such as the ChiNext 50 Index, which covers areas related to the construction of new power systems.

The ChiNext Board serves as a direct financing platform primarily for growth-oriented innovation and entrepreneurship enterprises characterized by the "Three Innovations" (innovation, creation, creativity) and "Four New" (new technologies, new industries, new business models, new formats) attributes. In terms of weighted industries, the ChiNext 50 Index focuses on four new productive force tracks: information technology, new energy, fintech, and pharmaceuticals, embodying a pure technology growth nature.

**ChiNext 50 Index: Chasing "Light," Identifying "New," and Excavating "Gold."** In a horizontal comparison, the ChiNext 50 Index demonstrates superior exposure to optical modules, new energy photovoltaics, and fintech compared to the ChiNext Index and other mainstream broad-based indices.

**ChiNext 50 ETF (159949): Aggregating Growth Blue-Chips in ChiNext's Leading Sectors** The ChiNext 50 ETF focuses on leading companies with strong technology growth attributes within the ChiNext market's advantageous fields. Its current valuation stands at 42.14 times P/E, at the 44.60% percentile over the past decade.

**Perspectives on Key Weighted Sectors of the ChiNext 50 Index (399673.SZ):**

* **Technology, AI, and Communications:** The ChiNext 50 Index encompasses 54% of the information technology industry, including companies with significant weights in optical modules and AI applications. Core constituents benefit from the expansion of global AI capital expenditures and validation of high industry prosperity. Last week, the optical module sector performed strongly. Key companies such as Zhongji Innolight, Eoptolink Technology, and TFC Optical Communication continued to benefit from the surge in AI computing demand. Notably, NVIDIA's $4 billion strategic investments in Lumentum and Coherent provided a significant boost to the global optical communication industry.

* **New Energy Photovoltaics:** Last week, the new energy photovoltaic sector experienced multiple policy and industry catalysts. Space-based photovoltaics are accelerating towards implementation: Microsoft signed a global cooperation agreement with Starlink, and SpaceX's third-generation Starship is expected to launch and attempt recovery within March, driving continued positive expectations. Huamin Co., Ltd. signed a strategic cooperation agreement with Hunan Aerospace Power Technology to develop flexible crystalline silicon solar cells and space-based photovoltaic systems, promoting the industrialization process. Module price recovery: Since the beginning of 2026, the photovoltaic industry has seen a collective price increase trend among leading companies. Trina Solar raised its module prices again by 0.01 RMB/W, with lightweight single-glass products breaking the 1 RMB/W threshold. Jinko Solar implemented price increases for its 650W+ Flying Tiger 3 series starting in March. Leading companies such as LONGi Green Energy Technology, JA Solar Technology, and TCL Zhonghuan synchronously raised their quotes, indicating a clear trend of industry price recovery.

* **Pharmaceuticals and Biotechnology:** The sector's underlying logic has formally shifted from "expectation recovery" to "performance and order fulfillment." The innovative drug industry chain is showing signs of recovery, displaying positive trends across multiple fronts including investment and financing data, order acquisition, and financial performance. CRO/CDMO sector inflection point: After entering March, innovative drug and CXO companies in A-shares, A+H shares, and Hong Kong stocks have successively disclosed annual reports, with Q1 performance becoming clearer. In February, overseas CXO companies' results and guidance were released, with several companies reporting revenue growth exceeding expectations and generally issuing slightly upgraded guidance. Coupled with expectations driven by volume growth in downstream innovative drug businesses and approvals for major products, valuations are expected to continue rising.

**Introduction to ChiNext 50 ETF (Code: 159949):** The ChiNext 50 ETF tracks the ChiNext 50 Index. Under the positioning criteria of the "Three Innovations" and "Four New," it primarily selects leading companies with high quality within five dominant technology sectors: new energy vehicles, biomedicine, electronics, photovoltaics, and internet finance. The ChiNext 50 Index reflects the overall performance of the 50 most prominent, liquid, and large-cap companies on the ChiNext market, representing relatively high investment value.

The ChiNext 50 ETF (Code: 159949) boasts ample liquidity, with an average daily turnover of 1.503 billion yuan over the past year, ranking among the top ETFs on the Shenzhen Stock Exchange. The latest fund size is 22.046 billion yuan, making it one of the larger funds tracking ChiNext-related indices in the market.

**Risk Warning:** The above content is solely an objective introduction to the current constituent distribution of the target index and does not constitute any investment advice or guarantee of investment returns. The index company may adjust the index compilation methodology subsequently, and the composition and weighting of index constituents may change dynamically. Please be aware of the risks associated with potentially high concentration and large weights of certain index constituents. This fund is an equity fund, categorized as a product with relatively high risk and high expected returns. It primarily invests in the constituent stocks and alternative constituent stocks of the target index. Its feeder fund mainly aims to closely track the performance of the target index by investing in the target ETF. This fund is expected to have higher returns and risks compared to money market funds, bond funds, and hybrid funds, exhibiting risk-return characteristics similar to the target index. The fund management company does not guarantee that the fund will be profitable, nor does it guarantee a minimum return. The past performance of the fund does not predict its future performance. The performance of other funds managed by the fund manager does not constitute a guarantee of this fund's performance. Fund product returns are subject to volatility risks. Investment requires caution. Please read the fund's contract, prospectus, and other legal documents carefully for details.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment